References
- Barbisan LF, Miyamoto M, Scolastici C, Salvadori DMF, Ribeiro LR, Eira AF, de Camargo JLV (2002): Influence of aqueous extract of Agaricus blazei. on rat liver toxicity induced by different doses of diethylnitrosamine. J Ethnopharmacol 83: 25–32. [PUBMED], [INFOTRIEVE], [CSA]
- Ebina T, Fujimiya Y (1998): Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei. in a double-grafted tumor system in mice. Biotherapy 11: 259–265. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hirotani M, Sai K, Nagai R, Hirotani S, Takayanagi H, Yoshikawa T (2002): Blazeispirane and protoblazeispirane derivatives from the cultured mycelia of the fungus Agaricus blazei.. Phytochemistry 61: 589–595 ( and literature cited therein). [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ito H, Shimura K, Itoh H, Kawade M (1997): Antitumor effect of a new polysaccharide-complex (ATOM) prepared from Agaricus blazei. (Iwade strain 101) “Himematsutake” and its mechanisms in tumor-bearing mice. Anticancer Res 17: 277–284. [PUBMED], [INFOTRIEVE], [CSA]
- Kawagishi H, Katumi R, Sazawa T, Mizuno T, Hagiwara T, Nakamura T (1988): Cytotoxic steroids from the mushroom Agaricus blazei.. Phytochemistry 27: 2777–2779. [CROSSREF], [CSA]
- Mizuno T (2002): Medicinal properties and clinical effects of culinary-medical mushroom Agaricus blazei. Murill (Agaricomycetideae). Int J Med Mushrooms 4: 299–312 ( and literature cited therein). [CSA]
- Mizuno T, Hagiwara T, Nakamura T, Ito H, Shimura K, Sumiya T, Asakura A (1990): Studies on the host-mediated anti-tumor polysaccharides from Himematsutake, the fruiting body of Agaricus blazei. Murill. Agric Biol Chem 54: 2889–2896. [CSA]
- Nakajima A, Ishida T, Koga M, Takeuchi T, Mazda O, Takeuchi M (2002): Effect of hot water extract from Agaricus blazei. Murill on antibody-producing cells in mice. Int Immunopharmacol 2: 1205–1211. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ohno N, Akanuma AM, Miura NN, Adachi Y, Motoi M (2001): (1–3)-β-D-Glucan in the fruit bodies of Agaricus blazei.. Pharm Pharmacol Lett 11: 87–90 ( and literature cited therein). [CSA]
- Osaki Y, Kato T, Yamamoto K, Okubo J, Miyazaki K (1994): Antimutagenic and bactericidal substances in the fruit body of a Bacidiomycete Agaricus blazei.. Yakugaku Zasshi 114: 342–350. [PUBMED], [INFOTRIEVE], [CSA]
- Pinheiro F, Faria RR, de Camargo JLV, Spinardi-Barbisan ALT, da Eira AF, Barbisan LF (2003): Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei. Murill in the rat. Foot Chem Toxical 41: 1543–1550. [CROSSREF], [CSA]
- Sorimachi K, Ikehara Y, Maezato G, Okubo A, Yamazaki S, Akimoto K, Niwa A (2001): Inhibition by Agaricus blazei. Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci Biotechnol Biochem 65: 1645–1647. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wasser SP, Weis AL (1999): Medicinal properties of substance occurring in higher Basidiomycetes mushrooms: Current perspectives. Int J Med Mushrooms 1: 31–62 ( and literature cited therein). [CSA]
- Watanabe T, Yamada T, Tanaka H, Jiang S, Mazumder TK, Nagai S, Tsuji K (2002): Antihypertensive effect of y-aminobutyric acid-enriched Agaricus blazei. on spontaneously hypertensive rats. Nippon Shokuhin Kagaku Kogaku Kaishi 49: 166–173. [CSA]